Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination

Mark D Grier1, Kathryn L West2, Nathaniel D Kelm2

  • 1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.

Plos One
|November 22, 2017
PubMed

Insights

The mechanistic target of rapamycin complex 2 (mTORC2) pathway plays a transient role in myelin development. Deleting Rictor in oligodendrocyte precursors impairs myelin formation, but recovery occurs over time.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Developmental Biology

Background:

  • Myelin abnormalities are linked to neurologic developmental disorders.
  • The PI3-K/mTOR pathway is crucial for myelinogenesis, with mTORC1's role established and mTORC2's role less understood.

Purpose of the Study:

  • To investigate the role of mTORC2 signaling in myelinogenesis.
  • To determine the specific function of mTORC2 in oligodendrocyte precursor cells (OPCs).

Main Methods:

  • Generated a conditional knockout (CKO) mouse model with Rictor deleted in OPCs.
  • Analyzed myelin-related protein expression, white matter tract size, myelinated axon density, and g-ratio.
  • Assessed OPC proliferation, oligodendrocyte numbers, and behavioral phenotypes in adult CKO mice.

Main Results:

  • Rictor deletion in OPCs decreased and delayed myelin protein expression and reduced white matter tract size.
  • Observed transient reductions in myelinated axon density and g-ratio, with improved myelination over time.
  • Found reduced OPC numbers at birth and proportionally fewer mature oligodendrocytes at P15, but no adult behavioral deficits.

Conclusions:

  • mTORC2 signaling, via Rictor in OPCs, plays an important but transient role in myelin development.
  • Despite initial deficits, the nervous system demonstrates plasticity and recovery in myelination.
  • These findings highlight mTORC2's contribution to the complex process of myelinogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
6.2K